Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the imagemagick-engine domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /usr/local/data/sites/proginres/htdocs-SSL/wp-includes/functions.php on line 6121

Notice: La funzione _load_textdomain_just_in_time è stata richiamata in maniera scorretta. Il caricamento della traduzione per il dominio ct è stato attivato troppo presto. Di solito è un indicatore di un codice nel plugin o nel tema eseguito troppo presto. Le traduzioni dovrebbero essere caricate all'azione init o in un secondo momento. Leggi Debugging in WordPress per maggiori informazioni. (Questo messaggio è stato aggiunto nella versione 6.7.0.) in /usr/local/data/sites/proginres/htdocs-SSL/wp-includes/functions.php on line 6121
cells – Progress in Research

Pioneering study sheds light on poorly understood aspect of cancer

A new scientific study published in the journal Science Advances has investigated a still poorly understood aspect of cancer, therapy-induced senescence in tumor cells. The study, the result of collaboration between researchers from Politecnico di Milano, Johns Hopkins University in Baltimore, the National Cancer Institute in Milan, and the National Research Council, expands our understanding of cancer biology and paves the way for future therapeutic advancements.

The team worked to uncover the biological mechanisms behind the formation of “therapy-induced senescent” (TIS) cells, a small percentage of treated tumor cells that exhibits resistance to conventional therapies (chemotherapy and radiation therapy), leading to tumor quiescence and ultimately, recurrence.

This result is a clear example of how cutting-edge technologies, multidisciplinary expertise, and strong international collaborations are crucial in addressing the most pressing biological questions, such as the early reaction mechanisms of tumor cells to anticancer therapies.

Arianna Bresci, first author of the study and doctoral student at Department of Physics

Researchers utilized advanced optical microscopy techniques, combining three-dimensional holograms of tumor cells with ultra-short pulses of laser light. They explored both the chemical and morphological aspects of TIS cells in human tumors, without the use of invasive techniques, preserving the natural state of the cells.

The research group was able to distinguish key features of TIS cells in human tumor cells: the reorganization of the mitochondrial network, overproduction of lipids, cell flattening, and enlargement. By analyzing a considerable number of cells, researchers established a clear timeline for the development of these distinctive signs.

This discovery may lead to applications in the development of personalized treatments and the possibility of refining current screening protocols for oncology therapy.

Our findings provide important insights into the complex world of TIS in human tumor cells. In our laboratory at Politecnico di Milano, we have developed a new non-invasive laser microscope that has allowed us to understand the initial stages of this phenomenon.

Dario Polli, associate professor at Department of Physics and coordinator of the study 

A revolution in the diagnosis and treatment of cancer

CHARM is a project aiming to develop a medical device based on high-speed, low-cost Raman digital imaging technology and artificial intelligence to transform cancer diagnosis and treatment.

The technology will analyse the molecular composition of patient tissue samples to distinguish cancerous from healthy cells without the need for chemical staining.

CHARM’s Raman imaging technology uses graphene-based ultra-fast fibre lasers to generate digital images of patient tissue for automatic analysis by artificial intelligence to support diagnosis. Because the images are digital, they can be viewed remotely, allowing histopathologists to work more efficiently and to support regions and countries short of qualified staff. The technology also potentially opens the way for personalised treatments for cancer.

The partners involved are Cambridge Raman Imaging Ltd. (CRI), a polimi spin-off, the University of Cambridge, Consiglio Nazionale delle Ricerche, Politecnico Di Milano, the Jena University Hospital (Germany) and the firms INsociety (Italy) and Inspiralia (Spain). The project coordinator is Dr Matteo Negro, CRI’s Chief Technology Officer.

CHARM is one of the 42 projects selected for a €3.3 million funding from 292 submitted in the first ever EIC (European Innovation Council) Transition Challenges, intended to support moving technologies from laboratories into the real world. The EIC is Europe’s flagship innovation programme to identify, develop and scale up breakthrough technologies and game changing innovations. In the case of CHARM, it aims to develop medical devices to the preclinical validation phase.

Politecnico di Milano, who pioneered the high-speed Raman imaging technology, will be responsible for the development of the microscope and the detection system.

I am excited to contribute to the translation of the results of our scientific studies into a commercial product which promises to significantly improve cancer diagnosis and therapy and have an important societal impact. To foster a close link between fundamental research and technological innovation is one of our main missions as academics and lies at the core of the EIC.

Prof. Giulio Cerullo, head of the ultrafast spectroscopy laboratory at Politecnico di Milano

Questo sito utilizza i cookies per le statistiche e per agevolare la navigazione nelle pagine del sito e delle applicazioni web. Maggiori informazioni sono disponibili alla pagina dell'informativa sulla privacy

Accetto